Angiopoietin-1 guides directional angiogenesis through integrin αvβ5 signaling for recovery of ischemic retinopathy

Science Translational Medicine

Volumn 5, Issue 203, 2013, Pages

  Lee, Junyeop ^a   Kim, Kyung Eun ^a   Choi, Dong Kyu ^a   Jang, Jeon Yeob ^a   Jung, Ji Jung ^a   Kiyonari, Hiroshi ^b   Shioi, Go ^b   Chang, Woohyok ^c   Suda, Toshio ^d   Mochizuki, Naoki ^e   Nakaoka, Yoshikazu ^f   Komuro, Issei ^f   Yoo, Ook Joon ^a   Koh, Gou Young ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

^c Yeungnam University College of Medicine   (South Korea)

^d KEIO UNIVERSITY   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA5 INTEGRIN; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; FIBRONECTIN; FOCAL ADHESION KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA ISCHEMIA; RETINA NERVE CELL; RETROLENTAL FIBROPLASIA; SIGNAL TRANSDUCTION;

ANGIOPOIETIN-1; ANIMALS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, VITRONECTIN; RETINA; RETINAL DISEASES; SIGNAL TRANSDUCTION;

EID: 84884686050     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006666     Document Type: Article

References (51)

1. P. Sapieha, J. S. Joyal, J. C. Rivera, E. Kermorvant-Duchemin, F. Sennlaub, P. Hardy, P. Lachapelle, S. Chemtob, Retinopathy of prematurity: Understanding ischemic retinal vasculopathies at an extreme of life. J. Clin. Invest. 120, 3022 -3032 (2010).
2. R. N. Frank, Diabetic retinopathy. N. Engl. J. Med. 350, 48-58 (2004).
3. J. Chen, L. E. Smith, Retinopathy of prematurity. Angiogenesis 10, 133-140 (2007).
4. H. P. Hammes, Y. Feng, F. Pfister, M. Brownlee, Diabetic retinopathy: Targeting vasoregression. Diabetes 60, 9-16 (2011).
5. R. F. Gariano, T. W. Gardner, Retinal angiogenesis in development and disease. Nature 438, 960-966 (2005).
6. M. Friedlander, Fibrosis and diseases of the eye. J. Clin. Invest. 117, 576-586 (2007).
7. L. P. Aiello, E. A. Pierce, E. D. Foley, H. Takagi, H. Chen, L. Riddle, N. Ferrara, G. L. King, L. E. Smith, Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U.S.A. 92, 10457-10461 (1995).
8. A. N. Witmer, G. F. Vrensen, C. J. Van Noorden, R. O. Schlingemann, Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22, 1-29 (2003).
9. H. A. Mintz-Hittner, K. A. Kennedy, A. Z. Chuang; BEAT-ROP Cooperative Group, Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N. Engl. J. Med. 364, 603-615 (2011).
10. VEGF Trap-Eye in clinical trials, National Institutes of Health, http://clinicaltrials.gov/ct2/results?term=VEGF+Trap-Eye+and+Eye+Disease.
11. M. Tolentino, Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv. Ophthalmol. 56, 95 -113 (2011).
12. M. Michaelides, A. Kaines, R. D. Hamilton, S. Fraser-Bell, R. Rajendram, F. Quhill, C. J. Boos, W. Xing, C. Egan, T. Peto, C. Bunce, R. D. Leslie, P. G. Hykin, A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: Report 2. Ophthalmology 117, 1078-1086.e2 (2010).
13. E. B. Rodrigues, M. E. Farah, M. Maia, F. M. Penha, C. Regatieri, G. B. Melo, M. M. Pinheiro, C. R. Zanetti, Therapeutic monoclonal antibodies in ophthalmology. Prog. Retin. Eye Res. 28, 117-144 (2009).
14. S. Schaal, H. J. Kaplan, T. H. Tezel, Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology 115, 2199-2205 (2008).
15. M. Saint-Geniez, A. S. Maharaj, T. E. Walshe, B. A. Tucker, E. Sekiyama, T. Kurihara, D. C. Darland, M. J. Young, P. A. D'Amore, Endogenous VEGF is required for visual function: Evidence for a survival role on Müller cells and photoreceptors. PLoS One 3, e3554 (2008).
16. T. Kurihara, P. D. Westenskow, S. Bravo, E. Aguilar, M. Friedlander, Targeted deletion of Vegfa in adult mice induces vision loss. J. Clin. Invest. 122, 4213-4217 (2012).
17. S. E. Quaggin, Turning a blind eye to anti-VEGF toxicities. J. Clin. Invest. 122, 3849-3851 (2012).
18. H. G. Augustin, G. Y. Koh, G. Thurston, K. Alitalo, Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165-177 (2009).
19. C. Suri, P. F. Jones, S. Patan, S. Bartunkova, P. C. Maisonpierre, S. Davis, T. N. Sato, G. D. Yancopoulos, Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180 (1996).
20. M. Jeansson, A. Gawlik, G. Anderson, C. Li, D. Kerjaschki, M. Henkelman, S. E. Quaggin, Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 121, 2278-2289 (2011).
21. G. Thurston, J. S. Rudge, E. Ioffe, H. Zhou, L. Ross, S. D. Croll, N. Glazer, J. Holash, D. M. McDonald, G. D. Yancopoulos, Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463 (2000).
22. C. H. Cho, K. E. Kim, J. Byun, H. S. Jang, D. K. Kim, P. Baluk, F. Baffert, G. M. Lee, N. Mochizuki, J. Kim, B. H. Jeon, D. M. McDonald, G. Y. Koh, Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ. Res. 97, 86-94 (2005).
23. G. Y. Koh, Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol. Med. 19, 31-39 (2013).
24. J. R. Gamble, J. Drew, L. Trezise, A. Underwood, M. Parsons, L. Kasminkas, J. Rudge, G. Yancopoulos, M. A. Vadas, Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 87, 603-607 (2000).
25. I. Kim, S. O. Moon, S. K. Park, S. W. Chae, G. Y. Koh, Angiopoietin-1 reduces VEGF- stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ. Res. 89, 477-479 (2001).
26. A. Uemura, M. Ogawa, M. Hirashima, T. Fujiwara, S. Koyama, H. Takagi, Y. Honda, S. J. Wiegand, G. D. Yancopoulos, S. Nishikawa, Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110, 1619-1628 (2002).
27. A. M. Joussen, V. Poulaki, A. Tsujikawa, W. Qin, T. Qaum, Q. Xu, Y. Moromizato, S. E. Bursell, S. J. Wiegand, J. Rudge, E. Ioffe, G. D. Yancopoulos, A. P. Adamis, Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 160, 1683-1693 (2002).
28. H. Nambu, R. Nambu, Y. Oshima, S. F. Hackett, G. Okoye, S. Wiegand, G. Yancopoulos, D. J. Zack, P. A. Campochiaro, Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood - retinal barrier. Gene Ther. 11, 865- 873 (2004).
29. C. H. Cho, R. A. Kammerer, H. J. Lee, K. Yasunaga, K. T. Kim, H. H. Choi,W. Kim, S. H. Kim, S. K. Park, G. M. Lee, G. Y. Koh, Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 101, 5553-5558 (2004).
30. P. Soriano, Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
31. T. Hato, Y. Kimura, T. Morisada, G. Y. Koh, K. Miyata, M. Tabata, T. Kadomatsu, M. Endo, T. Urano, F. Arai, K. Araki, T. Suda, K. Kobayashi, Y. Oike, Angiopoietins contribute to lung development by regulating pulmonary vascular network formation. Biochem. Biophys. Res. Commun. 381, 218-223 (2009).
32. B. Jiang, G. I. Liou, M. A. Behzadian, R. B. Caldwell, Astrocytes modulate retinal vasculogenesis: Effects on fibronectin expression. J. Cell Sci. 107 (Pt. 9), 2499-2508 (1994).
33. A. Uemura, S. Kusuhara, S. J. Wiegand, R. T. Yu, S. Nishikawa, Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J. Clin. Invest. 116, 369-377 (2006).
34. D. Stenzel, A. Lundkvist, D. Sauvaget, M. Busse, M. Graupera, A. van der Flier, E. S. Wijelath, J. Murray, M. Sobel, M. Costell, S. Takahashi, R. Fässler, Y. Yamaguchi, D. H. Gutmann, R. O. Hynes, H. Gerhardt, Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. Development 138, 4451-4463 (2011).
35. G. A. Lutty, D. S. McLeod, I. Bhutto, S. J. Wiegand, Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog. Invest. Ophthalmol. Vis. Sci. 52, 4039-4047 (2011).
36. K. A. Vessey, J. L. Wilkinson-Berka, E. L. Fletcher, Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy. J. Comp. Neurol. 519, 506-527 (2011).
37. E. Scheef, S. Wang, C. M. Sorenson, N. Sheibani, Isolation and characterization of murine retinal astrocytes. Mol. Vis. 11, 613-624 (2005).
38. M. Friedlander, C. L. Theesfeld, M. Sugita, M. Fruttiger, M. A. Thomas, S. Chang, D. A. Cheresh, Involvement of integrins avb3 and avb5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. U.S.A. 93, 9764-9769 (1996).
39. S. Hirota, Q. Liu, H. S. Lee, M. G. Hossain, A. Lacy-Hulbert, J. H. McCarty, The astrocyte-expressed integrin avb8 governs blood vessel sprouting in the developing retina. Development 138, 5157-5166 (2011).
40. I. Cascone, L. Napione, F. Maniero, G. Serini, F. Bussolino, Stable interaction between a5b1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J. Cell Biol. 170, 993 -1004 (2005).
41. S. M. Dallabrida, N. Ismail, J. R. Oberle, B. E. Himes, M. A. Rupnick, Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ. Res. 96, e8-e24 (2005).
42. J. T. Parsons, Focal adhesion kinase: The first ten years. J. Cell Sci. 116, 1409-1416 (2003).
43. J. Gavard, V. Patel, J. S. Gutkind, Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 14, 25-36 (2008).
44. S. Fukuhara, K. Sako, T. Minami, K. Noda, H. Z. Kim, T. Kodama, M. Shibuya, N. Takakura, G. Y. Koh, N. Mochizuki, Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat. Cell Biol. 10, 513-526 (2008).
45. P. Saharinen, L. Eklund, J. Miettinen, R. Wirkkala, A. Anisimov, M. Winderlich, A. Nottebaum, D. Vestweber, U. Deutsch, G. Y. Koh, B. R. Olsen, K. Alitalo, Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell- matrix contacts. Nat. Cell Biol. 10, 527-537 (2008).
46. M. I. Dorrell, E. Aguilar, R. Jacobson, S. A. Trauger, J. Friedlander, G. Siuzdak, M. Friedlander, Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia 58, 43-54 (2010).
47. M. Felcht, R. Luck, A. Schering, P. Seidel, K. Srivastava, J. Hu, A. Bartol, Y. Kienast, C. Vettel, E. K. Loos, S. Kutschera, S. Bartels, S. Appak, E. Besemfelder, D. Terhardt, E. Chavakis, T. Wieland, C. Klein, M. Thomas, A. Uemura, S. Goerdt, H. G. Augustin, Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J. Clin. Invest. 122, 1991-2005 (2012).
48. Y. Fukushima, M. Okada, H. Kataoka, M. Hirashima, Y. Yoshida, F. Mann, F. Gomi, K. Nishida, S. Nishikawa, A. Uemura, Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J. Clin. Invest. 121, 1974-1985 (2011).
49. K. M. Connor, N. M. Krah, R. J. Dennison, C. M. Aderman, J. Chen, K. I. Guerin, P. Sapieha, A. Stahl, K. L. Willett, L. E. Smith, Quantification of oxygen-induced retinopathy in the mouse: A model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4, 1565-1573 (2009).
50. Y. J. Koh, H. Z. Kim, S. I. Hwang, J. E. Lee, N. Oh, K. Jung, M. Kim, K. E. Kim, H. Kim, N. K. Lim, C. J. Jeon, G. M. Lee, B. H. Jeon, D. H. Nam, H. K. Sung, A. Nagy, O. J. Yoo, G. Y. Koh, Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage. Cancer Cell 18, 171-184 (2010).
51. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, A. Abramsson, M. Jeltsch, C. Mitchell, K. Alitalo, D. Shima, C. Betsholtz, VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177 (2003).